NCT06677242View on ClinicalTrials.gov

Serous Endometrial Intraepithelial Carcinoma (SEIC): Prospective Registration Study

Not yet recruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

April 1, 2025

Primary Completion Date

April 1, 2035

Study Completion Date

April 1, 2035

Conditions
Serous Endometrial Intraepithalial CarcinomaSEIC
Interventions
DIAGNOSTIC_TEST

Blood sample (serum) for circulating tumor DNA and cervical smear for genome-wide methylation sequencing

These are additional tests, added to the observational study to collect information on tumor characteristics and to pursue early detection of this diagnosis.

Trial Locations (1)

3045PM

Franciscus Gasthuis & Vlietland, Rotterdam

Sponsors
All Listed Sponsors
lead

Erasmus Medical Center

OTHER